23andMe+ Premium Membership Bundle - DNA Kit with Personal Genetic Insights Including Health + Ancestry Service Plus 1-Year Access to Exclusive Reports (Before You Buy See Important Test Info Below)

IMPORTANT: There is a lot to consider with genetic testing. Please review important information about Pharmacogenetics**, Carrier Status* and Genetic Health Risk* reports. Before purchasing, review important information at 23andme. com/test-info/pharmacogenetics and 23andme. com/test-info. A portion of your purchase may be eligible for FSA/HSA reimbursement***. Listed in TIME’s Best Inventions Hall of Fame 2025. ADVANCED ANCESTRY & HEALTH: Unlock 100+ reports and exclusive features with a 1-year prepaid membership. Get advanced genetic health insights like Pharmacogenetics (how your body processes certain medications**), preventive health features like Health TracksSM, and a personalized Health Action Plan. Trace your heritage faster with advanced filters, get access to 5,000 DNA Relatives, and Link to ancient figures with Historical MatchesSM. Valid payment method required at kit registration. CORE HEALTH FEATURES: This bundle includes the full Health + Ancestry Service. Discover how your DNA can affect your chances of developing certain health conditions* with personalized reports on health predispositions*. Learn about your carrier status* for inherited diseases, and optimize your routine with genetic wellness insights for sleep, diet, and exercise. Use these science-backed insights including FDA-authorized reports to take proactive control of your well-being. CORE ANCESTRY FEATURES: Explore your origins and dig deeper into your heritage with the world's most comprehensive ancestry breakdown across 4,500+ regions. Trace your maternal and paternal lines with Haplogroups, see your Neanderthal Ancestry, and get personal trait reports. Go back in time with the Ancestry Timeline to gain a clearer picture of ancestral story. Opt-in to the DNA Relative Finder and automatically build your Family Tree from your genetic relationships. PRIVATE & SECURE: Your DNA data is encrypted, protected, and always under your control. We implement enhanced security measures to keep your information safe. You choose what to learn and what to share. Privacy by design ensures your personal information is kept confidential. Subject to 23andMe’s Terms of Service at 23andme. com/tos and Privacy Statement at 23andme. com/about/privacy. * The 23andMe PGS test includes health predisposition and carrier status reports. Health predisposition reports include both reports that meet FDA requirements for genetic health risks and reports which are based on 23andMe research and have not been reviewed by the FDA. The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. **23andMe PGS Pharmacogenetics reports: The 23andMe test uses qualitative genotyping to detect 3 variants in the CYP2C19 gene, 2 variants in the DPYD gene and 1 variant in the SLCO1B1 gene in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic and does not describe the association between detected variants and any specific therapeutic. Our CYP2C19 Pharmacogenetics report provides certain information about variants associated with metabolism of some therapeutics and provides interpretive drug information regarding the potential effect of citalopram and clopidogrel therapy. Results for SLCO1B1 and DPYD and certain CYP2C19 results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For important information and limitations regarding Pharmacogenetics reports, visit 23andme. com/test-info/pharmacogenetics/ Membership auto-renews at then-current rate, unless canceled in advance. Once a 23andMe+ membership has ended, customer will lose access to 23andMe+ reports and features; customer will retain access to Health+Ancestry Service reports and features. Terms apply. Before you can use 23andMe and see your reports, you must agree to 23andMe's Terms of Service and Membership Terms at the time of registration of your 23andMe kit. Your use of 23andMe is further subject to 23andMe's Privacy Statement. For use in the USA only - kits shipped or used outside the US will be invalidated and no refund will be provided. Kits may not be redistributed or resold. 23andMe Claim Substantiation for "80% get genetically meaningful health info." Date range: August 2020 - August 2021. Source: 23andMe internal data.